BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23720089)

  • 1. New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography.
    Tanaka H; Iijima H; Higashiura A; Yoh K; Ishii A; Takashima T; Sakai Y; Aizawa N; Iwata K; Ikeda N; Iwata Y; Enomoto H; Saito M; Imanishi H; Hirota S; Fujimoto J; Nishiguchi S
    J Gastroenterol; 2014 Apr; 49(4):755-63. PubMed ID: 23720089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
    Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
    J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
    Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
    AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
    Kudo M; Hatanaka K; Inoue T; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():60-7. PubMed ID: 20616586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
    Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
    Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
    Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
    J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided diagnosis for estimating the malignancy grade of hepatocellular carcinoma using contrast-enhanced ultrasound: an ROC observer study.
    Sugimoto K; Shiraishi J; Tanaka H; Tsuchiya K; Aso K; Kobayashi Y; Iijima H; Moriyasu F
    Liver Int; 2016 Jul; 36(7):1026-32. PubMed ID: 26681659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading.
    Sugimoto K; Moriyasu F; Saito K; Taira J; Saguchi T; Yoshimura N; Oshiro H; Imai Y; Shiraishi J
    J Ultrasound Med; 2012 Apr; 31(4):529-38. PubMed ID: 22441909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
    Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M
    J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
    Chen S; Qiu YJ; Zhang Q; Lu XY; Huang YL; Dong Y; Wang WP
    Ultrasound Med Biol; 2024 Jan; 50(1):39-46. PubMed ID: 37778901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
    Kudo M; Hatanaka K; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
    Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
    Nuta J; Tamai H; Mori Y; Shingaki N; Maeshima S; Shimizu R; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Feb; 35(2):359-71. PubMed ID: 26782163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.
    Nishie A; Yoshimitsu K; Okamoto D; Tajima T; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Takayama Y; Shirabe K; Fujita N; Honda H
    Jpn J Radiol; 2013 Feb; 31(2):89-98. PubMed ID: 23070581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of sonazoid-ultrasonography during hepatectomy in patients with liver tumors: A preliminary study.
    Nanashima A; Tobinaga S; Abo T; Kunizaki M; Takeshita H; Hidaka S; Taura N; Ichikawa T; Sawai T; Nakao K; Nagayasu T
    J Surg Oncol; 2011 Feb; 103(2):152-7. PubMed ID: 21259249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor attenuation and quantitative analysis of perfusion parameters derived from tri-phasic CT scans in hepatocellular carcinoma: Relationship with histological grade.
    Pang G; Shao C; Lv Y; Zhao F
    Medicine (Baltimore); 2021 Apr; 100(16):e25627. PubMed ID: 33879737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation.
    Hiraoka A; Hiasa Y; Onji M; Michitaka K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):616-8. PubMed ID: 21418298
    [No Abstract]   [Full Text] [Related]  

  • 20. Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y; Terae S; Shirato H
    Jpn J Radiol; 2009 May; 27(4):185-93. PubMed ID: 19499310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.